Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,344 | 13,650 | 22,781 | 28,260 | 3,926 |
| Other current assets | 276 | 8 | 1 | 13 | 3 |
| TOTAL | $31,417 | $13,884 | $22,950 | $28,401 | $3,972 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 262 | 0 | 0 | 0 |
| TOTAL | $N/A | $262 | $N/A | $N/A | $N/A |
| Total Assets | $31,417 | $14,146 | $22,950 | $28,401 | $3,972 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,571 | 1,612 | 1,032 | 855 | 244 |
| Accrued Expenses | 776 | 659 | 605 | 622 | 125 |
| Other current liabilities | N/A | N/A | N/A | 167 | 33 |
| TOTAL | $2,347 | $2,271 | $1,637 | $1,644 | $402 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,347 | $2,271 | $1,637 | $1,644 | $402 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,003 | 19,896 | 19,896 | 18,465 | 13,643 |
| Common Shares | 140,733 | 106,392 | 106,392 | 103,045 | 74,515 |
| Retained earnings | -162,140 | -144,031 | -131,256 | -121,368 | -114,322 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $29,070 | $11,875 | $21,313 | $26,757 | $3,570 |
| Total Liabilities And Equity | $31,417 | $14,146 | $22,950 | $28,401 | $3,972 |